Implications of New Geological Mapping and U‐Pb Zircon Dating for the Barrovian Tectono‐Metamorphic Evolution of the Lepontine Dome (Central European Alps) von Tagliaferri, A., Schenker, F. L., Ulianov, A., Maino, M., Schmalholz, S. M.

Volltext

The importance of structural softening for the evolution and architecture of passive margins von Duretz, T., Petri, B., Mohn, G., Schmalholz, S. M., Schenker, F. L., Müntener, O.

Volltext

Current challenges for explaining (ultra)high-pressure tectonism in the Pennine domain of the Central and Western Alps von Schenker, F. L., Schmalholz, S. M., Moulas, E., Pleuger, J., Baumgartner, L. P., Podladchikov, Y., Vrijmoed, J., Buchs, N., Müntener, O.

Volltext

Polyphase evolution of Pelagonia (northern Greece) revealed by geological and fission-track data von Schenker, F. L, Fellin, M. G, Burg, J.-P

Volltext

Bimodal behavior of extended continental lithosphere: Modeling insight and application to thermal history of migmatitic core complexes von Schenker, F.L., Gerya, T., Burg, J.-P.

Volltext

Birth and closure of the Kallipetra Basin: Late Cretaceous reworking of the Jurassic Pelagonian-Axios/Vardar contact (northern Greece) von Bailey, Lydia R., Schenker, Filippo L., Fellin, Maria Giuditta, Cobianchi, Miriam, Adatte, Thierry, Picotti, Vincenzo

Volltext

AMON: a wearable multiparameter medical monitoring and alert system von Anliker, U., Ward, J.A., Lukowicz, P., Troster, G., Dolveck, F., Baer, M., Keita, F., Schenker, E.B., Catarsi, F., Coluccini, L., Belardinelli, A., Shklarski, D., Alon, M., Hirt, E., Schmid, R., Vuskovic, M.

Volltext

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy von Saukkonen, Jussi J, Cohn, David L, Jasmer, Robert M, Schenker, Steven, Jereb, John A, Nolan, Charles M, Peloquin, Charles A, Gordin, Fred M, Nunes, David, Strader, Dorothy B, Bernardo, John, Venkataramanan, Raman, Sterling, Timothy R, on behalf of ATS Hepatotoxicity of Antituberculosis Therapy Subcommittee

Volltext

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally adv... von Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.

Volltext

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma von Bellmunt, Joaquim, de Wit, Ronald, Vaughn, David J, Fradet, Yves, Lee, Jae-Lyun, Fong, Lawrence, Vogelzang, Nicholas J, Climent, Miguel A, Petrylak, Daniel P, Choueiri, Toni K, Necchi, Andrea, Gerritsen, Winald, Gurney, Howard, Quinn, David I, Culine, Stéphane, Sternberg, Cora N, Mai, Yabing, Poehlein, Christian H, Perini, Rodolfo F, Bajorin, Dean F

Volltext

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma von van der Heijden, Michiel S., Sonpavde, Guru, Powles, Thomas, Necchi, Andrea, Burotto, Mauricio, Schenker, Michael, Sade, Juan Pablo, Bamias, Aristotelis, Beuzeboc, Philippe, Bedke, Jens, Oldenburg, Jan, Chatta, Gurkamal, Ürün, Yüksel, Ye, Dingwei, He, Zhisong, Valderrama, Begoña P., Ku, Ja Hyeon, Tomita, Yoshihiko, Filian, Jeiry, Wang, Lily, Purcea, Daniela, Patel, Miraj Y., Nasroulah, Federico, Galsky, Matthew D.

Volltext

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma von Tawbi, Hussein A, Schadendorf, Dirk, Lipson, Evan J, Ascierto, Paolo A, Matamala, Luis, Castillo Gutiérrez, Erika, Rutkowski, Piotr, Gogas, Helen J, Lao, Christopher D, De Menezes, Juliana Janoski, Dalle, Stéphane, Arance, Ana, Grob, Jean-Jacques, Srivastava, Shivani, Abaskharoun, Mena, Hamilton, Melissa, Keidel, Sarah, Simonsen, Katy L, Sobiesk, Anne Marie, Li, Bin, Hodi, F. Stephen, Long, Georgina V

Volltext

Life cycle impact assessment of bio-based plastics from sugarcane ethanol von Tsiropoulos, I., Faaij, A.P.C., Lundquist, L., Schenker, U., Briois, J.F., Patel, M.K.

Volltext

Maximizing Information Yield From Pheromone-Baited Monitoring Traps: Estimating Plume Reach, Trapping Radius, and Absolute Density of Cydia pomonella (Lepidoptera: Tortricidae) in... von Adams, C. G, Schenker, J. H, McGhee, P. S, Gut, L. J, Brunner, J. F, Miller, J. R

Volltext

Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results from a Phase I/II Clinical Trial von Lewis, Richard A, Christie, William C, Day, Douglas G, Craven, E. Randy, Walters, Thomas, Bejanian, Marina, Lee, Susan S, Goodkin, Margot L, Zhang, Jane, Whitcup, Scott M, Robinson, Michael R

Volltext

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study von Harbeck, N., Rastogi, P., Martin, M., Tolaney, S.M., Shao, Z.M., Fasching, P.A., Huang, C.S., Jaliffe, G.G., Tryakin, A., Goetz, M.P., Rugo, H.S., Senkus, E., Testa, L., Andersson, M., Tamura, K., Del Mastro, L., Steger, G.G., Kreipe, H., Hegg, R., Sohn, J., Guarneri, V., Cortés, J., Hamilton, E., André, V., Wei, R., Barriga, S., Sherwood, S., Forrester, T., Munoz, M., Shahir, A., San Antonio, B., Nabinger, S.C., Toi, M., Johnston, S.R.D., O’Shaughnessy, J., Jimenez, M.M., Johnston, S., Boyle, F., Steger, G.G., Neven, P., Jiang, Z., Campone, M., Huober, J., Shimizu, C., Cicin, I., Wardley, A., Tolaney, S.M., Abuin, G.G., Zarba, J., Lim, E., Sant, P., Liao, N., Christiansen, B., Eigeliene, N., Martin-Babau, J., Ettl, J., Mavroudis, D., Chiu, J., Boer, K., Nagarkar, R., Paluch-Shimon, S., Moscetti, L., Sagara, Y., Kim, S.-B., Maciel, M.M., Tjan-Heijnen, V., Broom, R., Lacko, A., Schenker, M., Volkov, N., Sim Yap, Y., Coccia-Portugal, M., Ángel García Sáenz, J., Andersson, A., Chao, T.-Y., Gokmen, E., Harputluoglu, H., Berzoy, O., Patt, D., McArthur, H., Chew, H., Chalasani, P., Kaufman, P., Tedesco, K., Graff, S.L.

Volltext

Pulmonary vein reconnection and repeat ablation characteristics following cryoballoon‐compared to radiofrequency‐based pulmonary vein isolation von Obergassel, J., Nies, M., Taraba, S., Rottner, L., Lemoine, M. D., My, I., Moser, F., Rieß, J. L., Schenker, N., Dinshaw, L., Schleberger, R., Reißmann, B., Meyer, C., Willems, S., Rillig, A., Kirchhof, P., Metzner, A.

Volltext

Invited review: Advances and applications of random regression models: From quantitative genetics to genomics von Oliveira, H.R., Brito, L.F., Lourenco, D.A.L., Silva, F.F., Jamrozik, J., Schaeffer, L.R., Schenkel, F.S.

Volltext

First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update von Reck, M., Ciuleanu, T.-E., Cobo, M., Schenker, M., Zurawski, B., Menezes, J., Richardet, E., Bennouna, J., Felip, E., Juan-Vidal, O., Alexandru, A., Sakai, H., Lingua, A., Reyes, F., Souquet, P.-J., De Marchi, P., Martin, C., Pérol, M., Scherpereel, A., Lu, S., Paz-Ares, L., Carbone, D.P., Memaj, A., Marimuthu, S., Zhang, X., Tran, P., John, T.

Volltext